Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
Journal of Gastroenterology and Hepatology|January 5, 2013
Non-alcoholic fatty liver disease as an independent manifestation of the metabolic syndrome: results of a US national survey in three ethnic groupsMark M Smits, George N Ioannou, Edward J Boyko, et al.
Diabetes|January 31, 2024
In Vivo Inhibition of Dipeptidyl Peptidase 4 Allows Measurement of GLP-1 Secretion in MiceMark M Smits, Katrine D Galsgaard, Sara Lind Jepsen, et al.
American Journal of Physiology. Endocrinology and Metabolism|February 11, 2025
Single incretin receptor knockout mice do not compensate by increasing glucose-stimulated secretion of the remaining incretin hormoneKatrine D Galsgaard, Jon Vergara, Sara L Jepsen, et al.
Diabetes Research and Clinical Practice|June 18, 2022
Association between hypoglycaemic glucose variability and autonomic function in type1 diabetes with impaired hypoglycaemia awarenessCaterina Racca, Emma J Bouman, Cornelis A J Van Beers, et al.
Gut|January 21, 2016
GLP-1 based therapies: clinical implications for gastroenterologistsMark M Smits, Daniel H van Raalte, Lennart Tonneijck, et al.
Diabetes, Obesity & Metabolism|September 12, 2022
Mechanisms underlying the blood pressure-lowering effects of empagliflozin, losartan and their combination in people with type 2 diabetes: A secondary analysis of a randomized crossover trialRosalie A Scholtes, Charlotte M Mosterd, Anne C Hesp, et al.
Food Chemistry|August 14, 2024
Alpha-cyclodextrin increases glucagon-like peptide-1 secretion in multiple models and improves metabolic status in miceMark M Smits, Liv von Voss, Anna Katarzyna Drzazga, et al.
Nephrology (Carlton, Vic.)|August 21, 2019
Plasma uric acid and renal haemodynamics in type 2 diabetes patientsDanii Ls Suijk, Mark M Smits, Marcel Ha Muskiet, et al.
Diabetes Research and Clinical Practice|January 14, 2017
The effects of GLP-1 based therapies on postprandial haemodynamics: Two randomised, placebo-controlled trials in overweight type 2 diabetes patientsMark M Smits, Lennart Tonneijck, Marcel H A Muskiet, et al.
European Journal of Endocrinology|October 26, 2016
Heart rate acceleration with GLP-1 receptor agonists in type 2 diabetes patients: an acute and 12-week randomised, double-blind, placebo-controlled trialMark M Smits, Lennart Tonneijck, Marcel H A Muskiet, et al.
Pageof 7